Interestingly, STX3 expression was significantly elevated in PCa patients with low differentiation, stage III + IV, and lymph node metastasis compared to those with high differentiation, stage I + II, and absence of lymph node metastasis (Table 1). The gene discussed is STX3; the disease is metastatic malignant neoplasm in the lymph nodes.